April 14, 2016

DSN examines chain pharmacy, including in-depth coverage of specialty pharmacy, orphan drugs and biosimilars, in this multi-page report.

 

December 30, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, specialty pharmacy and top trends, in this multi-page report.

December 9, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, technology, automation, prescription drug home delivery services and Web-based diabetes monitoring, in this multi-page report.

November 11, 2015

DSN examines chain pharmacy, including in-depth coverage of generics, regulations, technology, automation and medication synchronization, in this multi-page report.

October 13, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

September 16, 2015

Although growth has been high for new specialty and brand-name drugs in the past year, generics continue to be a central part of the U.S. pharmaceutical market.

September 11, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

August 23, 2015

IMS Health’s Doug Long gave an overview of the present state of the U.S. pharmaceutical market and where it might be headed in the coming months and years at NACDS Total Store Expo on Sunday.

August 20, 2015

DSN examines chain pharmacy, including in-depth coverage of retail clinics, technology, automation, medication synchronization and generics, in this multi-page report.

July 28, 2015

Voters from all political parties support sunshine legislation that would make promote transparency in generic prescription drug payments by pharmacy benefit manager corporations, according to a national survey from the National Community Pharmacists Association released Tuesday.

July 28, 2015

Sandoz on Tuesday announced the launch of a generic version of AstraZeneca’s Pulmicort Respules (budesonide inhalation suspension) in 1-mg strength. Sandoz expects to have 180-day generic drug marketing exclusivity for the 1-mg strength.

July 27, 2015

The GpHA and Biosimilars Council have published their objections to the Trans-Pacific Partnership trade agreement to the pages of the New York Times. 

July 22, 2015

The Generic Pharmaceutical Association has appointed Chester “Chip” Davis, Jr. as president and CEO, replacing current CEO Ralph Neas effective Aug. 18.

July 21, 2015

According to NCPA CEO Douglas Hoey, independents dispensing generic medicines at a loss is not a sustainable business model.

July 17, 2015

The Trans-Pacific Partnership is setting a precedent that effectively can't be rolled back in the future, according to Congress leaders who hosted a press conference Friday morning.

July 16, 2015

The Food and Drug Administration recently issued its final guidance on the appearance of generic pharmaceuticals, recommending that drugs made by generic manufacturers closely mimic the physical attributes, including the size, shape and color, of the drugs that they reference.

July 16, 2015

Ralph Neas, president and CEO of the Generic Pharmaceutical Association, issued a statement last month criticizing the FDA at the organization’s public meeting on the Generic Drug User Free Act.

July 15, 2015

DSN examines chain pharmacy, including in-depth coverage of technology, automation, medication synchronization and generics, in this multi-page report.

July 15, 2015

A collection of eight consumer groups have written to Federal Trade Commission chair Edith Ramirez in opposition of the ongoing potential merger between pharmaceutical companies Teva and Mylan. 

July 9, 2015

Congress pressures CMS to create regulatory framework around generic drug price transparency. 

July 6, 2015

The Harvard Drug Group enhances Cardinal Health's generic distribution business, expands OTC portfolio. 

July 1, 2015

Teva Pharmaceuticals announced the U.S.-wide availability of generic Aggrenox (aspirin and extended-release dipyridamole) capsules, which contain that can reduce the risk of stroke, on Wednesday.

June 23, 2015

The Food and Drug Administration is concerned that too great a deviance from a reference drug appearance could affect compliance. 

June 23, 2015

Teva announced Monday that it had introduced its generic version of Focalin XR (dexmethylphenidate hydrochloride) extended-release capsules in a new 20-mg dosage strength.